Farmed Pig Castration and Alternatives for Boar Taint

Surgical castration of male piglets is performed to prevent boar taint in pork but causes acute pain and carries risks that welfare-compatible alternatives are addressing.

Key Facts

Around 80 million male piglets are surgically castrated annually in Europe to prevent boar taint in meat
Castration causes acute pain and is performed without anaesthetic in most European countries
Boar taint is caused by skatole and androstenone compounds accumulating in intact male carcasses
Immunocastration using Improvac vaccine prevents boar taint without surgery or ongoing pain
Slaughtering pigs before sexual maturity at lighter weights also prevents boar taint in most breeds
Denmark and Switzerland are moving toward universal pain relief or alternatives for piglet castration

Welfare Considerations

Piglet castration causes undeniable acute pain and potential chronic pain from surgical complications, yet is performed without anaesthetic in most European countries despite being technically banned without pain relief in many jurisdictions. The welfare case for alternatives is strong: immunocastration (Improvac) prevents boar taint without surgery and is accepted in Australia, the US, and increasingly in Europe. Early slaughter of males before sexual maturity is a production-system solution. Consumer resistance to immunocastration in some European markets has slowed adoption, representing a case where consumer preference contributes to ongoing animal suffering.

What You Can Do

Choose pork products from producers using immunocastration or early slaughter to avoid surgical castration
Support retailer commitments to phasing out surgical castration in their pork supply chains
Advocate for mandatory pain relief requirements when surgical castration continues to be practiced
Support consumer education campaigns explaining immunocastration as a welfare-positive alternative
Reduce pork consumption from producers continuing surgical castration without pain management protocols